Structures of biologically active muramyl peptides from peptidoglycan of Streptococcus sanguis.
The structures of major muramyl peptides derived from peptidoglycan of the oral pathogen Streptococcus sanguis were determined and the biological activity of the peptides was tested in vitro on human monocytes. The muramyl peptides, produced by muramidase digestion of the purified peptidoglycan, were separated by reversed-phase high-performance liquid chromatography, either in their native form or after reduction with sodium borohydride. Chemical structures of the peptides were elucidated by a combination of matrix-assisted laser desorption/ionization time-of-flight mass spectrometry, amino acid analysis, post-source decay analysis and Edman sequencing. The study revealed two distinct monomers: N-acetylglucosaminyl-N-acetylmuramyl-Ala-iGln-Lys(Ala-Ala) (1), where the Ala-Ala is connected to the epsilon-amino group of lysine, and N-acetylglucosaminyl-N-acetylmuramyl-Ala-iGln-Lys(Ala-Ala)-Ala-Ala (2), where an additional dialanyl residue is attached to the lysine alpha-carboxyl group. Two sets of higher oligomers (di-, tri- and tetramers), related structurally to monomers 1 or 2 were also detected. In these oligomers, the monomeric subunits are linked together by Ala-Ala-Ala bridges. The native muramyl peptides primed human monocytes in vitro for the increased production of the microbicidal superoxide radical.
Beranova-Giorgianni
S
S
Department of Oral Biology, University of Tennessee, Memphis 38163, USA.
Desiderio
D M
DM
Pabst
M J
MJ
D000595:Amino Acid Sequence; D001681:Biological Assay; D002240:Carbohydrate Sequence; D002851:Chromatography, High Pressure Liquid; D006801:Humans; D066298:In Vitro Techniques; D015394:Molecular Structure; D009000:Monocytes / Q000187:drug effects / Q000378:metabolism; D009112:Muramic Acids / Q000737:chemistry* / Q000302:isolation & purification / Q000494:pharmacology; D010457:Peptidoglycan / Q000737:chemistry* / Q000302:isolation & purification; D019032:Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; D013298:Streptococcus sanguis / Q000737:chemistry* / Q000472:pathogenicity; D013481:Superoxides / Q000378:metabolism
D009112:Muramic Acids; D010457:Peptidoglycan; D013481:Superoxides